financetom
Business
financetom
/
Business
/
Kimco Realty raises annual FFO forecast on strong leasing demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kimco Realty raises annual FFO forecast on strong leasing demand
Nov 3, 2024 3:33 PM

Oct 31 (Reuters) - Kimco Realty ( KIM ) raised its

forecast for annual funds from operations and beat Wall Street

estimates for third-quarter FFO on Thursday, helped by strong

leasing demand at the real estate investment trust's

grocery-anchored retail centers.

WHY IT IS IMPORTANT

A decline in new commercial space developments and fierce

competition among retailers have strengthened demand for rental

spaces, including strip mall centers, leading to a spike in

lease revenue.

KEY QUOTE

"Our high-quality, grocery-anchored properties continue to

deliver outsized growth, record occupancy and advantageous

pricing power," CEO Conor Flynn said in a statement.

"Moreover, our recent acquisition of the Waterford Lakes

Town Center in Orlando positions us to be a net acquirer in

2024."

BY THE NUMBERS

The Jericho, New York-based firm now expects its full-year

FFO - a key REIT metric that defines cash flow from core

operations - to be between $1.64 and $1.65 per share, compared

with its previous range of $1.60 to $1.62 per share.

Kimco's ( KIM ) portfolio occupancy rate rose by 90 basis points

year-on-year to 96.4% in the quarter.

Total quarterly revenue rose nearly 14% to $507.6 million,

versus estimates of a 12.63% rise to $497.6 million. Its net

revenue from rental properties also jumped 14%.

Third-quarter FFO rose 7.5% to 43 cents per share. Analysts

had expected 41 cents.

Kimco ( KIM ) raised its total acquisitions forecast for the year to

between $565 million and $625 million, from its previous

projection of $300 million to $350 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New US tariffs could prompt Signify to move some production from China, CEO says
New US tariffs could prompt Signify to move some production from China, CEO says
Nov 3, 2024
AMSTERDAM (Reuters) - Lighting maker Signify is considering moving some of its production out of China if the company is confronted with a new round of U.S. tariffs, its chief executive said on Friday. Signify, the world's biggest maker of lights, is looking at production sites in India, Indonesia and changing existing operations in Mexico, CEO Eric Rondolat said on...
IDEAYA Biosciences Reports 'Positive' Interim Phase 1 Data for Cancer Drug; Shares Rise Pre-Bell
IDEAYA Biosciences Reports 'Positive' Interim Phase 1 Data for Cancer Drug; Shares Rise Pre-Bell
Nov 3, 2024
08:06 AM EDT, 10/25/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) reported positive interim expansion data Friday for IDE397 in patients with methylthioadenosine phosphorylase-deletion urothelial cancer and non-small cell lung cancer. The oncology company said that it observed a manageable safety profile with no drug-related serious adverse events or discontinuations at the 30mg once-a-day expansion dose. Shares of IDEAYA...
New US tariffs could prompt Signify to move some production from China, CEO says
New US tariffs could prompt Signify to move some production from China, CEO says
Nov 3, 2024
AMSTERDAM, Oct 25 (Reuters) - Lighting maker Signify is considering moving some of its production out of China if the company is confronted with a new round of U.S. tariffs, its chief executive said on Friday. Signify, the world's biggest maker of lights, is looking at production sites in India, Indonesia and changing existing operations in Mexico, CEO Eric Rondolat...
Market Chatter: AstraZeneca's Former Executives Under Investigation in China
Market Chatter: AstraZeneca's Former Executives Under Investigation in China
Nov 3, 2024
08:08 AM EDT, 10/25/2024 (MT Newswires) -- AstraZeneca's ( AZN ) former senior executive is being investigated by Chinese authorities, Bloomberg reported on Friday, citing local media outlets. The report said Eva Yin, currently the Chief Commercial Officer for Beigene, was recently detained. It added that Yin had worked at AstraZeneca ( AZN ) for over 15 years, including serving...
Copyright 2023-2025 - www.financetom.com All Rights Reserved